Symbol Name ID |
Ifng
interferon gamma MGI:107656 |
Darker colors indicate more annotations |
Human Phenotypes | Decreased circulating IgA level |
Decreased circulating IgG level |
Decreased circulating IgG2 level |
Defective B cell differentiation |
Bleeding with minor or no trauma |
Epistaxis |
Gingival bleeding |
Gastrointestinal hemorrhage |
Hematemesis |
Melena |
Intracranial hemorrhage |
Intraventricular hemorrhage |
Joint hemorrhage |
Muscle hemorrhage |
Oral cavity bleeding |
Persistent bleeding after trauma |
Bruising susceptibility |
Purpura |
Petechiae |
Spontaneous hematomas |
Bone marrow hypocellularity |
Pancytopenia |
Aplastic anemia |
Anemia |
Abnormal B cell count |
Decreased proportion of CD4-positive helper T cells |
T lymphocytopenia |
Lymphopenia |
Leukocytosis |
Abnormality of neutrophils |
Hemophagocytosis |
Leukemia |
Acute lymphoblastic leukemia |
T-cell acute lymphoblastic leukemias |
Arterial thrombosis |
Thromboembolism |
Reduced factor VIII activity |
Prolonged partial thromboplastin time |
Abnormality of thrombocytes |
Thrombocytosis |
Lymphoma |
Hodgkin lymphoma |
Non-Hodgkin lymphoma |
Elevated erythrocyte sedimentation rate |
Splenic rupture |
Splenomegaly |
Hepatosplenomegaly |
Disease(s) Associated with IFNG | |||||||||||||||||||||||||||||||||||||||||||||||
acute lymphoblastic leukemia | |||||||||||||||||||||||||||||||||||||||||||||||
aplastic anemia | |||||||||||||||||||||||||||||||||||||||||||||||
ataxia telangiectasia | |||||||||||||||||||||||||||||||||||||||||||||||
chronic granulomatous disease | |||||||||||||||||||||||||||||||||||||||||||||||
factor VIII deficiency | |||||||||||||||||||||||||||||||||||||||||||||||
graft-versus-host disease | |||||||||||||||||||||||||||||||||||||||||||||||
immunodeficiency 69 | |||||||||||||||||||||||||||||||||||||||||||||||
rheumatoid arthritis | |||||||||||||||||||||||||||||||||||||||||||||||
temporal arteritis |
Mouse Phenotypes | abnormal dendritic cell chemotaxis |
abnormal macrophage chemotaxis |
abnormal diapedesis |
increased splenocyte proliferation |
abnormal uterine NK cell morphology |
increased uterine NK cell number |
thymus atrophy |
enlarged spleen |
decreased common myeloid progenitor cell number |
abnormal erythropoiesis |
abnormal B cell differentiation |
extramedullary hematopoiesis |
anemia |
impaired hematopoiesis |
abnormal bone marrow cell morphology/development |
decreased myeloid cell number in bone marrow |
decreased bone marrow cell number |
decreased granulocyte monocyte progenitor cell number |
decreased megakaryocyte cell number |
decreased erythroid progenitor cell number |
abnormal proerythroblast morphology |
increased erythroblast number |
decreased erythrocyte cell number |
increased hematocrit |
increased nucleated erythrocyte cell number |
increased neutrophil cell number |
increased granulocyte number |
thrombocytopenia |
decreased mature B cell number |
decreased pre-B cell number |
increased CD8-positive, alpha-beta T cell number |
increased NK T cell number |
increased T cell number |
increased lymphocyte cell number |
increased macrophage cell number |
increased monocyte cell number |
decreased leukocyte cell number |
increased leukocyte cell number |
pancytopenia |
increased hematopoietic stem cell number |
abnormal hematopoietic stem cell morphology |
decreased megakaryocyte-erythroid progenitor cell number |
abnormal spleen morphology |
abnormal spleen red pulp morphology |
spleen atrophy |
abnormal spleen white pulp morphology |
pale spleen |
abnormal B cell physiology |
abnormal immunoglobulin level |
decreased IgA level |
decreased IgE level |
increased IgE level |
increased IgG1 level |
decreased IgG2a level |
decreased IgG2b level |
decreased IgG3 level |
decreased IgG level |
decreased IgM level |
decreased immunoglobulin level |
abnormal NK cell physiology |
impaired natural killer cell mediated cytotoxicity |
abnormal uterine NK cell physiology |
abnormal cytotoxic T cell physiology |
abnormal T cell activation |
abnormal macrophage physiology |
abnormal MHC II cell surface expression on macrophages |
|
Availability | Mouse Genotype | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ifngtm1.1Hayg/Ifngtm1.1Hayg | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ifngtm1Ts/Ifngtm1Ts | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ifngtm1.1(KOMP)Vlcg/Ifng+ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|